Q3 2024 Xtant Medical Holdings Inc Earnings Call Transcript

Nov 12, 2024 / 09:30 PM GMT

Release Date Price: $0.54 (+4.09%)

Transcript 10-Q8-K

Key Points

Positve

Xtant Medical Holdings Inc (XTNT) reported a solid 12% growth for the third quarter and 36% growth year-to-date.
The company reaffirmed its full-year revenue guidance of $116 to $120 million, representing a 27% to 31% increase compared to 2023.
Xtant Medical Holdings Inc (XTNT) successfully launched two new products, Osteovive Plus and Cortera, which are expected to drive future growth.
The company signed a licensing agreement in October, providing a minimum of $3.75 million in royalty revenues for 2025.
Xtant Medical Holdings Inc (XTNT) is focused on bringing manufacturing in-house, which is expected to significantly improve gross margins from mid-40s to low-90s percent.

Negative

Sales were softer than expected due to delays in the launch of new products and supplier issues.
Gross margin decreased to 58.4% in Q3 2024 from 61.3% in the same period in 2023, primarily due to reduced throughput.
Operating expenses increased to $20.1 million in Q3 2024 from $18.7 million in the same period a year ago.
The company reported a net loss of $5 million in Q3 2024 compared to a net income of $9.2 million in Q3 2023.
There was a noted softness in the procedure environment during the summer months, attributed to doctors taking vacations.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

XTNT.A - Xtant Medical Holdings Inc
Q3 2024 Xtant Medical Holdings Inc Earnings Call
Nov 12, 2024 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Exxon Medical Holdings Inc third quarter, 2024 conference call at this time. All participants are in a listen-only later. We will conduct a question and answer session. I would now like to turn the call over to your host, Brett Moss Investor Relations. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you operator.

--------------------------------------------------------------------------------
Unidentified_3 [3]
--------------------------------------------------------------------------------
Joining me

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.